RECENT POST

August 3, 2026 00:00 |  

Covington Associates

View News

October 12, 2015 06:38 AM  |   Covington Associates

Locemia Solutions acquired by Eli Lilly and Company

Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).